Source: Eur Respir J 2016; 47:1392-1401
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Locke Landon W., Myerburg Michael M., Weiner Daniel J., Markovetz Matthew R., Parker Robert S., Muthukrishnan Ashok, Weber Lawrence, Czachowski Michael R., Lacy Ryan T., Pilewski Joseph M., Corcoran Timothy E.. Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung. Eur Respir J 2016; 47:1392-1401

Member's Comments

No comment yet.

Related content which might interest you: Long-term clearance from small airways in patients with cystic fibrosis Source: Eur Respir J 2005; 25: 317-323 Year: 2005 Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005 Improving airway clearance in cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 169-187 Year: 2014 Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect Source: Eur Respir J 2004; 24: 95-100 Year: 2004 Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung Source: Eur Respir J , 49 (4)  1602108; DOI: 10.1183/13993003.02108-2016 Year: 2017 Impact of Pseudomonas aeruginosa infection on Na+ transport in airway epithelia Source: Annual Congress 2007 - The impact of viral and bacterial infection on the respiratory epithelium Year: 2007 Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway Source: Eur Respir J 2010; 35: 781-786 Year: 2010 Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017 Year: 2018 New insights into the pathophysiology of lung disease in cystic fibrosis patients Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1 Year: 2006 Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007 Cystic fibrosis lung disease: from molecular defect to abnormal mucocilliary clearance Source: Annual Congress 2007 - PG4 - Paediatric respiratory medicine: cystic fibrosis – the basics Year: 2007 Airway clearance techniques in cystic fibrosis Source: Eur Respir J 2006; 27: 1082-1083 Year: 2006 Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002 Emerging pathogens in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66 Year: 2006 Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis Source: Eur Respir J 2001; 18: 316-322 Year: 2001 Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017 Year: 2017 Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens Source: Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019 Year: 2019 Azithromycin in chronic respiratory infections with pseudomonas aeruginosa in patients without cystic fibrosis Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008